Expected Moves

First quarter results will test if holiday or restructuring initiatives are yielding a top-line turnaround.

High probability of a capital raise to recapitalize the balance sheet before cash runs out.

Q2 earnings, typically coupled with updated corporate strategy if a recapitalization has occurred.

Third quarter results to confirm margin sustainability and potential growth in specialty drug channels.